Metabolomics Market

High Performance Liquid Chromatography and Mass Spectrometry Technique Lead the Market

The global metabolomics market is poised to grow at a high CAGR of 30% from 2014 to 2019. The increase in government and private funding for metabolomics research and the growing demand for personalized medicine are some of the major factors driving the growth of the metabolomics market. Moreover, growth in the pharmaceutical and biotechnology industries is also expected to contribute to the growth of the metabolomics market during the forecast period of 2014 to 2019.

In the techniques segment, high performance liquid chromatography (HPLC) accounted for the largest share of 38% of the global metabolomics market in 2014. The large share of this segment can be attributed to its wide application in biomarker discovery. The market is driven by the increase in research funding from governments and private investors in the metabolomics field.

Geographically, in 2014, the global metabolomics market was dominated by North America, primarily due to the presence of major metabolomics companies in the U.S. Increasing demand for personalized medicine is the major driver for this market in North America. By 2019, Europe will continue to dominate the market; the market share of this region is expected to increase to 49% by 2019 from 37% in 2014.

During the forecast period, a majority of the growth in the global metabolomics market will largely be driven by the growing pharmaceutical and biotechnology industries in the Asian market, especially in Japan and China. Countries like Japan, China, and Singapore are also developing sophisticated technologies for drug discovery and early diagnosis of various diseases, which is expected to boost the APAC metabolomics market. On the other hand, the European market is largely driven by the growth in Germany due to vast developments in metabolomic sciences, especially in the drug discovery and toxicology assessment fields.

Related Reports:

Metabolomics Market by Technique (Gas Chromatography, High Performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry), Application (Biomarker & Drug Discovery, Nutrigenomics) & by Indication (Oncology, Cardiology) - Global Forecast to 2019

Contact:
Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com

Report Code
BT 2550
Published ON
Mar, 2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Metabolomics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved